These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Acute systematic inflammatory response syndrome and serum biomarkers predict outcomes after subarachnoid hemorrhage. Hokari M; Uchida K; Shimbo D; Gekka M; Asaoka K; Itamoto K J Clin Neurosci; 2020 Aug; 78():108-113. PubMed ID: 32600972 [TBL] [Abstract][Full Text] [Related]
5. Leukocytosis as an independent risk factor for cerebral vasospasm following aneurysmal subarachnoid hemorrhage. McGirt MJ; Mavropoulos JC; McGirt LY; Alexander MJ; Friedman AH; Laskowitz DT; Lynch JR J Neurosurg; 2003 Jun; 98(6):1222-6. PubMed ID: 12816268 [TBL] [Abstract][Full Text] [Related]
6. Persistent perioperative hyperglycemia as an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage. McGirt MJ; Woodworth GF; Ali M; Than KD; Tamargo RJ; Clatterbuck RE J Neurosurg; 2007 Dec; 107(6):1080-5. PubMed ID: 18077943 [TBL] [Abstract][Full Text] [Related]
8. Blood pressure changes after aneurysmal subarachnoid hemorrhage and their relationship to cerebral vasospasm and clinical outcome. Faust K; Horn P; Schneider UC; Vajkoczy P Clin Neurol Neurosurg; 2014 Oct; 125():36-40. PubMed ID: 25083804 [TBL] [Abstract][Full Text] [Related]
9. Early Vasospasm after Aneurysmal Subarachnoid Hemorrhage Predicts the Occurrence and Severity of Symptomatic Vasospasm and Delayed Cerebral Ischemia. Jabbarli R; Reinhard M; Shah M; Roelz R; Niesen WD; Kaier K; Taschner C; Weyerbrock A; Van Velthoven V Cerebrovasc Dis; 2016; 41(5-6):265-72. PubMed ID: 26836215 [TBL] [Abstract][Full Text] [Related]
10. Systemic Inflammatory Response Syndrome as Predictor of Poor Outcome in Nontraumatic Subarachnoid Hemorrhage Patients. Rass V; Gaasch M; Kofler M; Schiefecker AJ; Ianosi BA; Rhomberg P; Beer R; Pfausler B; Gizewski ER; Thomé C; Schmutzhard E; Helbok R Crit Care Med; 2018 Dec; 46(12):e1152-e1159. PubMed ID: 30252711 [TBL] [Abstract][Full Text] [Related]
11. The Role of ABO Blood Group in Cerebral Vasospasm, Associated Intracranial Hemorrhage, and Delayed Cerebral Ischemia in 470 Patients with Subarachnoid Hemorrhage. Dubinski D; Won SY; Konczalla J; Mersmann J; Geisen C; Herrmann E; Seifert V; Senft C World Neurosurg; 2017 Jan; 97():532-537. PubMed ID: 27777156 [TBL] [Abstract][Full Text] [Related]
12. Cocaine use is an independent risk factor for cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Conway JE; Tamargo RJ Stroke; 2001 Oct; 32(10):2338-43. PubMed ID: 11588323 [TBL] [Abstract][Full Text] [Related]
13. Intraoperative rerupture during surgical treatment of aneurysmal subarachnoid hemorrhage is not associated with an increased risk of vasospasm. Sheth SA; Hausrath D; Numis AL; Lawton MT; Josephson SA J Neurosurg; 2014 Feb; 120(2):409-14. PubMed ID: 24313615 [TBL] [Abstract][Full Text] [Related]
14. The Association Between Spontaneous Hyperventilation, Delayed Cerebral Ischemia, and Poor Neurological Outcome in Patients with Subarachnoid Hemorrhage. Williamson CA; Sheehan KM; Tipirneni R; Roark CD; Pandey AS; Thompson BG; Rajajee V Neurocrit Care; 2015 Dec; 23(3):330-8. PubMed ID: 25846710 [TBL] [Abstract][Full Text] [Related]
15. The relationship between ruptured aneurysm location, subarachnoid hemorrhage clot thickness, and incidence of radiographic or symptomatic vasospasm in patients enrolled in a prospective randomized controlled trial. Abla AA; Wilson DA; Williamson RW; Nakaji P; McDougall CG; Zabramski JM; Albuquerque FC; Spetzler RF J Neurosurg; 2014 Feb; 120(2):391-7. PubMed ID: 24313610 [TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Rosengart AJ; Schultheiss KE; Tolentino J; Macdonald RL Stroke; 2007 Aug; 38(8):2315-21. PubMed ID: 17569871 [TBL] [Abstract][Full Text] [Related]
17. The Effects of Red Blood Cell Transfusion on Functional Outcome after Aneurysmal Subarachnoid Hemorrhage. Kumar MA; Levine J; Faerber J; Elliott JP; Winn HR; Doerfler S; Le Roux P World Neurosurg; 2017 Dec; 108():807-816. PubMed ID: 29038077 [TBL] [Abstract][Full Text] [Related]
18. Early predictors of outcome in patients receiving hypervolemic and hypertensive therapy for symptomatic vasospasm after subarachnoid hemorrhage. Qureshi AI; Suarez JI; Bhardwaj A; Yahia AM; Tamargo RJ; Ulatowski JA Crit Care Med; 2000 Mar; 28(3):824-9. PubMed ID: 10752836 [TBL] [Abstract][Full Text] [Related]
19. The postoperative C-reactive protein level can be a useful prognostic factor for poor outcome and symptomatic vasospasm in patients with aneurysmal subarachnoid hemorrhage. Jeon YT; Lee JH; Lee H; Lee HK; Hwang JW; Lim YJ; Park HP J Neurosurg Anesthesiol; 2012 Oct; 24(4):317-24. PubMed ID: 22732721 [TBL] [Abstract][Full Text] [Related]
20. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study. Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]